In clinical research, automated flags on lab results are standard, but relying solely on them for safety signals can be dangerous. Experts argue that waiting for a system alert is insufficient for patient safety. Instead, they advocate for proactive data monitoring, where e-source documentation is redesigned to include built-in prompts that ensure vital indicators—such as liver enzymes—are assessed at every visit, regardless of standard reporting thresholds. This shift from passive observation to active oversight is critical for effective clinical trial management.
Clinical Lab Data: Why Waiting for Automated Alerts Puts Patients at Risk
AI
May 4, 2026 · 2:09 AM